Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2017.05.357
Abstract: PURPOSE The EINSTEIN-Extension trial showed that an extended rivaroxaban treatment significantly reduced the risk for venous thromboembolic (VTE) recurrence. The present study assessed the risk for VTE recurrence and major bleeding associated with extended rivaroxaban… read more here.
Keywords: risk; recurrence; among patients; treatment ... See more keywords
Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/10760296231158368
Abstract: Cancer is a risk factor for venous thromboembolism (VTE). We aimed to define sex-specific risk of preceding cancer in patients with a first-time VTE by conducting a nationwide Swedish registry-based study including 298 172 patients with… read more here.
Keywords: cancer patients; venous thromboembolism; patients vte; women men ... See more keywords